Pereckaite L, Tatarunas V, Giedraitiene A. Current antimicrobial susceptibility testing for beta-lactamase-producing Enterobacteriaceae in clinical settings. J Microbiol Methods. 2018;152:154–164. https://doi.org/10.1016/j.mimet.2018.07.014. Epub 2018 Jul 29. PMID: 30063958.

Samreen, Ahmad I, Malak HA, Abulreesh HH. Environmental antimicrobial resistance and its drivers: a potential threat to public health. J Glob Antimicrob Resist. 2021;27:101–11. https://doi.org/10.1016/j.jgar.2021.08.001. Epub 2021 Aug 25. PMID: 34454098.

Article  CAS  Google Scholar 

Septimus EJ. Antimicrobial resistance: an antimicrobial/Diagnostic stewardship and infection prevention approach. Med Clin North Am. 2018;102(5):819–29. https://doi.org/10.1016/j.mcna.2018.04.005. Epub 2018 Jun 27. PMID: 30126573.

Article  PubMed  Google Scholar 

Rajasekar SJS, Thiyagarajan S, Mohamed Ali S. Ab.ai - A Novel Automated AI Tool for Reporting Antibiograms. Stud Health Technol Inform. 2022;299:202–207. https://doi.org/10.3233/SHTI220984. PMID: 36325864.

Morrison L, Zembower TR. Antimicrobial resistance. Gastrointest Endosc Clin N Am. 2020;30(4):619–35. https://doi.org/10.1016/j.giec.2020.06.004. Epub 2020 Aug 1. PMID: 32891221.

Article  PubMed  Google Scholar 

Saeed DK, Farooqi J, Shakoor S, Hasan R. Antimicrobial resistance among GLASS priority pathogens from Pakistan: 2006–2018. BMC Infect Dis. 2021;21(1):1231. https://doi.org/10.1186/s12879-021-06795-0. PMID: 34876041; PMCID: PMC8650393.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liebchen U, Weinelt F, Scharf C, Schroeder I, Paal M, Zoller M, Kloft C, Jung J, Michelet R. Combination of Pharmacokinetic and pathogen susceptibility information to optimize meropenem treatment of Gram-Negative infections in critically ill patients. Antimicrob Agents Chemother. 2022;66(2):e0183121. Epub 2021 Dec 6. PMID: 34871092; PMCID: PMC8846453.

Article  PubMed  Google Scholar 

Lob SH, Hoban DJ, Young K, Motyl MR, Sahm DF. Activity of Imipenem/relebactam against Gram-negative bacilli from global ICU and non-ICU wards: SMART 2015–2016. J Glob Antimicrob Resist. 2018;15:12–9. https://doi.org/10.1016/j.jgar.2018.05.017. Epub 2018 May 29. PMID: 29857057.

Article  PubMed  Google Scholar 

Liu L, Ni Y. Antimicrobial susceptibilities of specific syndromes created with organ-specific weighted incidence antibiograms (OSWIA) in patients with intra-abdominal infections. BMC Infect Dis. 2018;18(1):584. https://doi.org/10.1186/s12879-018-3494-x. PMID: 30453893; PMCID: PMC6245934.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ribeiro ÁCDS, Crozatti MTL, Silva AAD, Macedo RS, Machado AMO, Silva ATA. Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption. Rev Soc Bras Med Trop. 2019;53:e20180498. https://doi.org/10.1590/0037-8682-0498-2018. PMID: 31859938; PMCID: PMC7083346.

Article  PubMed  PubMed Central  Google Scholar 

Fernández J, Vazquez F. The Importance of Cumulative Antibiograms in Diagnostic Stewardship. Clin Infect Dis. 2019;69(6):1086–1087. https://doi.org/10.1093/cid/ciz082. PMID: 30715204.

Pascucci M, Royer G, Adamek J, Asmar MA, Aristizabal D, Blanche L, Bezzarga A, Boniface-Chang G, Brunner A, Curel C, Dulac-Arnold G, Fakhri RM, Malou N, Nordon C, Runge V, Samson F, Sebastian E, Soukieh D, Vert JP, Ambroise C, Madoui MA. AI-based mobile application to fight antibiotic resistance. Nat Commun. 2021;12(1):1173. https://doi.org/10.1038/s41467-021-21187-3. PMID: 33608509; PMCID: PMC7895972.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fridkin SK, Pack J, Licitra G, Zheng Z, Watkins R, Price S, Camp M, Moore R. Creating reasonable antibiograms for antibiotic stewardship programs in nursing homes: analysis of 260 facilities in a large geographic region, 2016–2017. Infect Control Hosp Epidemiol. 2019;40(8):839–46. Epub 2019 May 28. PMID: 31133088.

Article  PubMed  Google Scholar 

Lanckohr C, Bracht H. Antimicrobial stewardship. Curr Opin Crit Care. 2022;28(5):551–556. doi: 10.1097/MCC.0000000000000967. Epub 2022 Aug 4. PMID: 35942707.

Hatsuda Y, Ishizaka T, Koizumi N, Yasui Y, Saito T, Maki S, Omotani S, Mukai J, Tachi T, Teramachi H, Myotoku M. Influence of analysis conditions for antimicrobial susceptibility test data on susceptibility rates. PLoS ONE. 2020;15(6):e0235059. https://doi.org/10.1371/journal.pone.0235059. PMID: 32574199; PMCID: PMC7310835.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hindler JA, Schuetz AN, June. CLSI Subcommittee on Antimicrobial Susceptibility Testing, CLSI AST News Update. Volume 7, Issue 1, 2022, https://clsi.org/media/rcqcsoad/ast-news-update-volume-7-issue-1-june-2022.pdf

Teitelbaum D, Elligsen M, Katz K, Lam PW, Lo J, MacFadden D, Vermeiren C, Daneman N. Introducing the Escalation Antibiogram: A Simple Tool to Inform Changes in Empiric Antimicrobials in the Nonresponding Patient. Clin Infect Dis. 2022;75(10):1763–1771. https://doi.org/10.1093/cid/ciac256. PMID: 35380628.

Hughes MA, Dosa DM, Caffrey AR, Appaneal HJ, Jump RLP, Lopes V, LaPlante KL. Antibiograms cannot be used interchangeably between acute care medical centers and affiliated nursing homes. J Am Med Dir Assoc. 2020;21(1):72–7. https://doi.org/10.1016/j.jamda.2019.07.016. Epub 2019 Sep 16. PMID: 31537479; PMCID: PMC7233453.

Article  PubMed  Google Scholar 

Vo QT, Klevens RM, Bolstorff B, Barton K, Cumming M, Blumenthal JA, Troppy TS, Gerth JM, DeMaria A. Utilization of cumulative antibiograms for public health surveillance: trends in Escherichia coli and Klebsiella pneumoniae susceptibility, Massachusetts, 2008–2018. Infect Control Hosp Epidemiol. 2021;42(2):169–75. Epub 2020 Aug 27. PMID: 32847644.

Article  PubMed  Google Scholar 

Burillo A, Muñoz P, Bouza E. Risk stratification for multidrug-resistant Gram-negative infections in ICU patients. Curr Opin Infect Dis. 2019;32(6):626–637. https://doi.org/10.1097/QCO.0000000000000599. PMID: 31567570.

Haider MH, McHugh TD, Roulston K, Arruda LB, Sadouki Z, Riaz S. Detection of carbapenemases blaOXA48-blaKPC-blaNDM-blaVIM and extended-spectrum-β-lactamase blaOXA1-blaSHV-blaTEM genes in Gram-negative bacterial isolates from ICU burns patients. Ann Clin Microbiol Antimicrob. 2022;21(1):18. https://doi.org/10.1186/s12941-022-00510-w. Erratum in: Ann Clin Microbiol Antimicrob. 2022;21(1):34. PMID: 35590320; PMCID: PMC9121598.

Puzniak L, DePestel DD, Srinivasan A, Ye G, Murray J, Merchant S, DeRyke CA, Gupta V. A combination antibiogram evaluation for Pseudomonas aeruginosa in respiratory and blood sources from intensive care unit (ICU) and Non-ICU settings in U.S. Hospitals. Antimicrob Agents Chemother. 2019;63(4):e02564–18. https://doi.org/10.1128/AAC.02564-18. PMID: 30917987; PMCID: PMC6496158.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Henderson A, Paterson DL, Chatfield MD, Tambyah PA, Lye DC, De PP, Lin RTP, Chew KL, Yin M, Lee TH, Yilmaz M, Cakmak R, Alenazi TH, Arabi YM, Falcone M, Bassetti M, Righi E, Rogers BA, Kanj SS, Bhally H, Iredell J, Mendelson M, Boyles TH, Looke DFM, Runnegar NJ, Miyakis S, Walls G, Khamis MAI, Zikri A, Crowe A, Ingram PR, Daneman N, Griffin P, Athan E, Roberts L, Beatson SA, Peleg AY, Cottrell K, Bauer MJ, Tan E, Chaw K, Nimmo GR, Harris-Brown T, Harris PNA, MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study. Clin Infect Dis. 2021;73(11):e3842-e3850. https://doi.org/10.1093/cid/ciaa1479. PMID: 33106863.

Etani T, Mogami T, Yamaguchi S, Takeda T, Sugino T, Shimizu N, Noda Y, Nagai T, Nozaki S, Iida K, Naiki T, Ando R, Kawai N, Yasui T. Comparison of drug susceptibility between Escherichia coli detected in stool cultures of patients undergoing transrectal prostate needle biopsy and Escherichia coli in hospital-wide urine antibiograms. J Infect Chemother. 2022;28(2):343–6. https://doi.org/10.1016/j.jiac.2021.10.022. Epub 2021 Nov 5. PMID: 34750049.

Article  CAS  PubMed  Google Scholar 

winKaram G, Chastre J, Wilcox MH, Vincent JL. Antibiotic strategies in the era of multidrug resistance. Crit Care. 2016;20(1):136. https://doi.org/10.1186/s13054-016-1320-7. PMID: 27329228; PMCID: PMC4916531.

Article  Google Scholar 

Wu C, Lu J, Ruan L, Yao J. Tracking epidemiological characteristics and risk factors of Multi-Drug resistant Bacteria in intensive care units. Infect Drug Resist. 2023;16:1499–509. https://doi.org/10.2147/IDR.S386311. PMID: 36945682; PMCID: PMC10024905.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shawa M, Paudel A, Chambaro H, Kamboyi H, Nakazwe R, Alutuli L, Zorigt T, Sinyawa T, Samutela M, Chizimu J, Simbotwe M, Hayashida K, Nao N, Kajihara M, Furuta Y, Suzuki Y, Sawa H, Hang’ombe B, Higashi H. Trends, patterns and relationship of antimicrobial use and resistance in bacterial isolates tested between 2015–2020 in a National referral hospital of Zambia. PLoS ONE. 2024;19(4):e0302053. https://doi.org/10.1371/journal.pone.0302053. PMID: 38625961; PMCID: PMC11020921.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Munting A, Damas J, Viala B, Prod’hom G, Guery B, Senn L. Impact of selective reporting of antibiotic susceptibility testing results on meropenem prescriptions for the treatment of Pseudomonas aeruginosa infections after 2020 EUCAST criteria update: an observational study in a university hospital. Antimicrob Resist Infect Control. 2022;11(1):165. https://doi.org/10.1186/s13756-022-01203-x. PMID: 36585736; PMCID: PMC9805013.

Article  PubMed  PubMed Central  Google Scholar 

Sommerstein R, Damonti L, Marschall J, Harbarth S, Gasser M, Kronenberg A, Buetti N. Distribution of pathogens and antimicrobial resistance in ICU-bloodstream infections during hospitalization: a nationwide surveillance study. Sci Rep. 2021;11(1):16876. https://doi.org/10.1038/s41598-021-95873-z. PMID: 34413340; PMCID: PMC8376881.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Acam J, Kuodi P, Medhin G, Makonnen E. Antimicrobial prescription patterns in East Africa: a systematic review. Syst Reviews. 2023;12(1):18. https://doi.org/10.1186/s13643-022-02152-7.

Article  Google Scholar 

Chernov VM, Chernova OA, Mouzykantov AA, Lopukhov LL, Aminov RI. Omics of antimicrobials and antimicrobial resistance. Expert Opin Drug Discov. 2019;14(5):455–68. Epub 2019 Mar 19. PMID: 30884978.

Article  CAS  PubMed  Google Scholar 

Chelkeba L, Melaku T. Epidemiology of Staphylococci species and their antimicrobial-resistance among patients with wound infection in Ethiopia: a systematic review and meta-analysis. J Glob Antimicrob Resist. 2022;29:483–98. https://doi.org/10.1016/j.jgar.2021.10.025. Epub 2021 Nov 18. PMID: 34801740.

Article  CAS  PubMed  Google Scholar 

Godman B, Egwuenu A, Wesangula E, Schellack N, Kalungia AC, Tiroyakgosi C, Kgatlwane J, Mwita JC, Patrick O, Niba LL, Amu AA, Oguntade RT, Alabi ME, Ncube NBQ, Sefah IA, Acolatse J, Incoom R, Guantai AN, Oluka M, Opanga S, Chikowe I, Khuluza F, Chiumia FK, Jana CE, Kalemeera F, Hango E, Fadare J, Ogunleye OO, Ebruke BE, Meyer JC, Massele A, Malande OO, Kibuule D, Kapona O, Zaranyika T, Bwakura-Dangarembizi M, Kujinga T, Saleem Z, Kurdi A, Shahwan M, Jairoun AA, Wale J, Brink AJ. Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future. Expert Opin Drug Saf. 2022;21(8):1089–111. https://doi.org/10.1080/14740338.2022.2106368. Epub 2022 Aug 30. PMID: 35876080.

Article